We are live on ! Find out more
ENDP

Endo International plc

Delisted

ENDP was delisted on the 25th of August, 2022.

190 hedge funds and large institutions have $717M invested in Endo International plc in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 66 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $19.1M | Put options by funds: $14.9M

12% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 66

7% less funds holding

Funds holding: 205190 (-15)

21% less capital invested

Capital invested by funds: $905M → $717M (-$188M)

47% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 32

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
190
Holders Change
-15
Holders Change %
-7.32%
% of All Funds
4.15%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
17
Increased
74
Reduced
66
Closed
32
Calls
$19.1M
Puts
$14.9M
Net Calls
+$4.21M
Net Calls Change
-$94.6M

ENDP Hedge Fund Activity: Q3 2019 in Review

190 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Endo International plc (ENDP) for Q3 2019, worth a combined $717M — down 21% from $905M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ENDP and 17 opened new positions — a net loss of 15 holders — while 66 trimmed existing stakes and 74 added.

The largest buyer was Glenview Capital Management, adding an estimated $23.4M. The largest seller was OrbiMed, exiting entirely with an estimated $25.4M sold.

  • 190 institutional investors held Endo International plc (ENDP) as of Q3 2019, down from 205 in Q2 2019.
  • Funds reported $717M of Endo International plc stock for Q3 2019, down 21% quarter-over-quarter.
  • 17 funds opened new Endo International plc positions in Q3 2019 and 32 closed out, a net change of -15 holders.
  • The largest Endo International plc buyer in Q3 2019 was Glenview Capital Management, an estimated $23.4M added.
  • The largest Endo International plc seller in Q3 2019 was OrbiMed, an estimated $25.4M sold.

Based on aggregated 13F filings for Q3 2019.